Erin Darakjian - 28 Nov 2022 Form 4 Insider Report for P3 Health Partners Inc. (PIII)

Role
Interim CFO, Senior VP & CAO
Signature
/s/ Jessica Puathasnanon, as attorney-in-fact
Issuer symbol
PIII
Transactions as of
28 Nov 2022
Net transactions value
$0
Form type
4
Filing time
30 Nov 2022, 15:05:26 UTC
Previous filing
09 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PIII Stock Option (Right to Buy) Award $0 +100,000 $0.000000 100,000 28 Nov 2022 Class A Common Stock 100,000 $4.62 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable with respect to 25% of the shares on each of October 18, 2023, October 18, 2024, October 18, 2025 and October 18, 2026, subject to the Reporting Person's continued service through the applicable vesting date.